Concepedia

Tomoko Yamakura

TY

2

Publications

44

Citations

2

H-Index

2017

Active since

Affiliations

Mitsubishi Group (Japan)(Current)

Mitsubishi Tanabe Pharma Corporation

Tomoko Yamakura is an author at Mitsubishi Group (Japan).

Publications per year

2017–2017

2

Publications

2

Safety and efficacy of canagliflozin in elderly patients with type 2 diabetes mellitus: a 1-year post-marketing surveillance in Japan

Maki Goda, Tomoko Yamakura, Kazuyo Sasaki et al. · Current Medical Research and Opinion · 2017 · 31 citations · Full text

Safety and efficacy of long-term treatment with teneligliptin: Interim analysis of a post-marketing surveillance of more than 10,000 Japanese patients with type 2 diabetes mellitus

Takashi Kadowaki, Masakazu Haneda, Hiroshi Ito et al. · Expert Opinion on Pharmacotherapy · 2017 · 13 citations · Full text

Rows per page

1–2 of 2